Fundraising Fox

Glympse Bio

Cambridge, US · Founded 2015 · Delaware corporation · 2 known investors

glympsebio.com ↗
Biotech

Founders & leadership

TG
Theresia GuowDirector
SR
Sirshendu Roopom BanerjeeExecutive Officer
GK
Gabriel KwongExecutive Officer
SL
Stan LapidusDirector
AS
Amy SchulmanDirector

Investors · 2

GreatPoint VenturesSan Francisco · $250K – $20M
Polaris PartnersreportedBoston · $500K – $5Mvia Amy Schulman · board

Reported raises · per SEC filings

Form D private placements
▶$23.2MraisedMay 2023 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ALEXANDRA CANTLEYDirector
  • STANLEY LAPIDUSDirector
  • JOHN MCDONOUGHDirector
  • YINGMIN WANGDirector
  • HUILIN SHAODirector
  • STEVE KAFKADirector
Offering amount
$23.2M
Amount sold
$23.2M
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18MraisedDec 2021 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Caroline LoewExecutive Officer, Director
  • Theresia GouwDirector
  • Amy SchulmanDirector
  • Stanley LapidusDirector
  • Robert LangerDirector
  • Francis CussDirector
  • Tram TranExecutive Officer
  • Steve KafkaDirector
  • Wendy Winckler AdamovichExecutive Officer
  • Jessica AtkinsonExecutive Officer
  • Dhaval GosaliaExecutive Officer
  • Matthew NavarroExecutive Officer
  • George ZacharyDirector
Offering amount
$18M
Amount sold
$18M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$46.7MraisedJul 2021 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Theresia GouwDirector
  • Jessica AtkinsonExecutive Officer
  • Amy SchulmanDirector
  • Steve KafkaDirector
  • Stanley LapidusDirector
  • Francis CussDirector
  • Dhaval GosaliaExecutive Officer
  • Robert LangerDirector
  • George ZacharyDirector
  • Wendy Winckler AdamovichExecutive Officer
  • Caroline LoewExecutive Officer, Director
Offering amount
$46.7M
Amount sold
$46.7M
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$26.1MraisedAug 2018 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Theresia GuowDirector
  • Sirshendu Roopom BanerjeeExecutive Officer
  • Gabriel KwongExecutive Officer
  • Stan LapidusDirector
  • Amy SchulmanDirector
Offering amount
$30.1M
Amount sold
$26.1M
Proceeds to insiders
$900K
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.